Xwell (XWEL) Cash from Operations Growth (1y) (2011 - 2026)
Xwell (XWEL) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | -10.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.15% |
| Dec 31, 2025 | 98.79% |
| Sep 30, 2025 | 38.32% |
| Jun 30, 2025 | -438.60% |
| Mar 31, 2025 | -13.47% |
| Dec 31, 2024 | -8.22% |
| Sep 30, 2024 | 19.72% |
| Jun 30, 2024 | 83.91% |
| Mar 31, 2024 | 37.22% |
| Dec 31, 2023 | 52.80% |
| Sep 30, 2023 | 51.60% |
| Jun 30, 2023 | 59.76% |
| Mar 31, 2023 | -230.61% |
| Dec 31, 2022 | -178.92% |
| Sep 30, 2022 | -212.98% |
| Jun 30, 2022 | -506.24% |
| Mar 31, 2022 | 49.29% |
| Dec 31, 2021 | 206.28% |
| Sep 30, 2021 | 249.43% |
| Jun 30, 2021 | 120.53% |